BTMD vs IONS · P/E 5.3, rev $89.2M vs rev $514.0M
biote Corp (BTMD) versus Ionis Pharmaceuticals Inc (IONS) — a side-by-side from cached financials, not a winner call.
biote Corp (BTMD) is a medical care facilities company listed on NASDAQ.
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
Latest reported BTMD revenue for 2026-06-30 was $89.2M. Net income was -$4.3M. Revenue was up 98.4% from 2026-03-31 to 2026-06-30. BTMD currently screens at market cap $80.7M and trailing P/E 5.3.
Latest reported IONS revenue for 2026-06-30 was $514.0M. Net income was -$207.2M. IONS currently screens at market cap $12.28B.
BTMD currently screens at market cap $80.7M and trailing P/E 5.3. IONS currently screens at market cap $12.28B.
Not investment advice. Open the BTMD and IONS stock pages for the full models.
Not investment advice.